Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Balslev

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 19, 2016
Expression Patterns of Biomarkers in Primary Tumors and Corresponding Metastases in Breast CancerIben Kümler, Eva Balslev, Ann S Knop, et al.
Blood|September 16, 2004
Immunogenicity of Bcl-2 in patients with cancerMads Hald Andersen, Inge Marie Svane, Pia Kvistborg, et al.
Annals of Surgical Oncology|May 27, 2021
Prediction of Pathologic Complete Response in Breast Cancer Patients Comparing Magnetic Resonance Imaging with Ultrasound in Neoadjuvant SettingFrederik Knude Palshof, Charlotte Lanng, Niels Kroman, et al.
Acta Oncologica (Stockholm, Sweden)|December 24, 2013
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patientsCharlotte L T Jørgensen, Torsten O Nielsen, Karsten D Bjerre, et al.
Acta Oncologica (Stockholm, Sweden)|April 8, 2004
Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probesKaren E Olsen, Helle Knudsen, Birgitte B Rasmussen, et al.
Frontiers in Oncology|June 26, 2018
Evidence of No Association Between Human Papillomavirus and Breast CancerSara Bønløkke, Jan Blaakær, Torben Steiniche, et al.
Breast Cancer Research and Treatment|June 18, 2010
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancerKirsten Vang Nielsen, Bent Ejlertsen, Sven Müller, et al.
Breast Cancer Research and Treatment|April 26, 2011
Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancerMogens Bernsdorf, Eva Balslev, Anne E Lykkesfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2009
Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group StudyGro L Willemoe, Pernille B Hertel, Annette Bartels, et al.
International Journal of Cancer|October 25, 2007
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survivalAnne Roslind, Julia S Johansen, Ib J Christensen, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 19, 2016
Expression Patterns of Biomarkers in Primary Tumors and Corresponding Metastases in Breast CancerIben Kümler, Eva Balslev, Ann S Knop, et al.
Blood|September 16, 2004
Immunogenicity of Bcl-2 in patients with cancerMads Hald Andersen, Inge Marie Svane, Pia Kvistborg, et al.
Annals of Surgical Oncology|May 27, 2021
Prediction of Pathologic Complete Response in Breast Cancer Patients Comparing Magnetic Resonance Imaging with Ultrasound in Neoadjuvant SettingFrederik Knude Palshof, Charlotte Lanng, Niels Kroman, et al.
Acta Oncologica (Stockholm, Sweden)|December 24, 2013
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patientsCharlotte L T Jørgensen, Torsten O Nielsen, Karsten D Bjerre, et al.
Acta Oncologica (Stockholm, Sweden)|April 8, 2004
Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probesKaren E Olsen, Helle Knudsen, Birgitte B Rasmussen, et al.
Frontiers in Oncology|June 26, 2018
Evidence of No Association Between Human Papillomavirus and Breast CancerSara Bønløkke, Jan Blaakær, Torben Steiniche, et al.
Breast Cancer Research and Treatment|June 18, 2010
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancerKirsten Vang Nielsen, Bent Ejlertsen, Sven Müller, et al.
Breast Cancer Research and Treatment|April 26, 2011
Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancerMogens Bernsdorf, Eva Balslev, Anne E Lykkesfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2009
Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group StudyGro L Willemoe, Pernille B Hertel, Annette Bartels, et al.
International Journal of Cancer|October 25, 2007
High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survivalAnne Roslind, Julia S Johansen, Ib J Christensen, et al.
Pageof 9